CPRI CEO John Idol Sells 91,398 Shares

John Idol, the CEO of CPRI, recently sold a significant number of shares, while other major institutions adjusted their positions.

Key Points

  • John Idol, Chairman & CEO of CPRI, sold 91,398 shares on June 16, 2026, without a planned sale arrangement.
  • CPRI shares trade near $20.76, with major institutional investors like BlackRock and FMR LLC adjusting their holdings.
  • Analysts from UBS and Telsey Advisory Group maintain a hold rating, while JP Morgan and BTIG reiterate a buy rating.

John Idol, Chairman and CEO of CPRI, sold 91,398 shares of the company on June 16, 2026. The transaction was not part of a pre-planned sale. This move comes amid various institutional investors adjusting their stakes in CPRI.

Other Institutional Activity in CPRI

Several major institutional investors have recently changed their holdings in CPRI. BlackRock, Inc. increased its position by 244,773 shares, bringing its total to 14,265,870 shares valued at approximately $251.4 million. On the other hand, FMR LLC reduced its stake by 3,571,981 shares, now holding 10,768,256 shares worth about $189.7 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both established new positions, each holding 5,698,764 and 5,160,197 shares respectively. DME Capital Management, LP also increased its stake by 162,311 shares, totaling 4,930,318 shares valued at around $86.9 million.

CPRI Stock Snapshot

CPRI shares are currently trading near $20.76. The stock has been subject to fluctuations as institutional investors adjust their positions. This activity reflects ongoing interest and evaluation by major funds.

Insider Buying and Selling at CPRI

In addition to John Idol's sale, several other insider transactions occurred around the same time. Jenna Hendricks, Chief People Officer, sold 9,766 shares but also made a purchase of the same amount on June 17, 2026. Krista McDonough, Chief Legal & Sustainability Officer, sold 9,766 shares on the same day. These transactions indicate a mix of buying and selling activities among CPRI's top executives.

Analysts Set New Price Targets

Analyst firms have maintained their ratings on CPRI. On May 28, 2026, UBS, Telsey Advisory Group, Wells Fargo, and B of A Securities all maintained a hold rating with price targets around $20 to $21. JP Morgan and BTIG reiterated buy ratings, with targets of $29 and $30, respectively. The consensus among analysts suggests a cautious yet optimistic outlook, with a mean target price reflecting moderate growth potential.

Bottom Line

John Idol's recent sale of CPRI shares highlights the dynamic nature of insider and institutional activity within the company. Investors closely watch such moves for insights into company performance and future prospects. The ongoing adjustments by major funds and analysts' maintained ratings underscore the stock's current position in the market. As always, it's important to remember that these insider transactions and institutional filings are backward-looking and may not reflect current strategies.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.